• Study validates standard of care therapies in morphea

    1 month ago - By Healio

    Standard of care treatments for morphea yielded reasonable success over long-term follow-up, according to a study.
    “Prospective studies of the disease course in patients with morphea are lacking, particularly those comparing adults and children,” Jack C. O'Brien, MD, of the department of dermatology at the University of Texas Southwestern Medical Center, Dallas, and colleagues wrote.
    In the prospective cohort study, the researchers aimed to assess morphea disease course in 130 adults and children who had been treated with standard of care treatment protocols using validated
    Read more ...

     

  • Genetic Test Identifies Ultra-High-Risk Myeloma Patients

    1 month ago - By Medscape

    UK researchers have identified a subgroup of patients with ultra-high-risk multiple myeloma who are unlikely to respond to the commonly used maintenance therapy.
    Medscape Medical News
    Read more ...

     

  • Desiccated Thyroid Better Than Standard Therapy, Say Patients

    1 month ago - By Medscape

    Patients with hypothyroidism taking desiccated thyroid extract such as Armour perceive it works better than synthetic levothyroxine alone, despite lack of data and known risks.
    Medscape Medical News
    Read more ...